Clinical Trial Update: First-in-Man Trial of NNC114-0005 in Healthy Subjects and Subjects With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A first-in-man Phase 1 study evaluating safety and pharmacology of NNC114-0005 in healthy subjects and individuals with rheumatoid arthritis, now completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• NNC114-0005

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Inflammation, Rheumatoid Arthritis | Phase 1 | Status: COMPLETED